Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin- resistant Staphylococcus aureus
- 1 January 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Hospital Infection
- Vol. 53 (1) , 58-63
- https://doi.org/10.1053/jhin.2002.1332
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effect of norepinephrine on the outcome of septic shockCritical Care Medicine, 2000
- Regional Prophylaxis with Teicoplanin in Monolateral or Bilateral Total Knee Replacement: an Open StudyAntimicrobial Agents and Chemotherapy, 2000
- Clinical Gram-positive sepsisCritical Care Medicine, 1999
- Efficacy and pharmacodynamics of teicoplanin given daily during the first 3 days and then on alternate days for methicillin-resistant Staphylococcus aureus infectionsJournal of Antimicrobial Chemotherapy, 1999
- Prospective, double-blind, randomized trial of teicoplanin versus vancomycin for the therapy of vascular access-associated bacteremia caused by gram-positive pathogensJournal of Infection and Chemotherapy, 1999
- Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiberIntensive Care Medicine, 1998
- Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shockJournal of Infection, 1998
- Extracorporeal Endotoxin Removal by Polymyxin B Immobilized Fiber Cartridge: Designing and Antiendotoxin Efficacy in the Clinical ApplicationTherapeutic Apheresis, 1998
- Treatment of sepsis by plasma endotoxin removal: hemoperfusion using a polymyxin-B immobilized columnInnate Immunity, 1997
- Gram-positive Organisms and SepsisArchives of internal medicine (1960), 1994